Revenue Components (Tables)

12 Months Ended

Mar. 31, 2022

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table provides information about the Company’s revenues (in thousands):

	Year Ended March 31,
	2022		2021		2020
Revenues:
Product revenue, net:
ORGOVYX	$	82,959	$	3,630	$	—
MYFEMBREE	6,355		—		—
Richter product supply and royalties	4,995		—		—
Total product revenue, net	94,309		3,630		—
Pfizer collaboration revenue:
Amortization of upfront payment	83,897		22,354		—
Amortization of regulatory milestone	21,099		—		—
Total Pfizer collaboration revenue	104,996		22,354		—
Richter license and milestone revenue	31,667		33,333		—
Total revenues	$	230,972	$	59,317	$	—

Revenue from External Customers by Geographic Areas

Product revenue, net by geography consisted of the following (in thousands):

	Year Ended March 31,
	2022		2021		2020
United States	$	89,314	$	3,630	$	—
Europe	4,995		—		—
Total product revenue, net	$	94,309	$	3,630	$	—

Summary Of Categories Of Discounts And Allowances

The activities and ending balances for each significant category of discounts and allowances (which constitutes variable consideration) for the years ended March 31, 2022 and 2021 were as follows (in thousands):

	Reserve -government and other incentives		Chargebacks and administrative fees		Returns		Sales Discounts		Total
Balance as of March 31, 2020	$	—	$	—	$	—	$	—	$	—
Provision related to sales in the current year	1,351		363		109		109		1,932
Credits and payments made during the current year	(508)		—		—		(30)		(538)
Balance as of March 31, 2021	843		363		109		79		1,394
Provision related to sales in the current year	38,910		13,384		2,919		2,377		57,590
Adjustments related to prior year sales	(305)		(124)		—		—		(429)
Credits and payments made during the current year	(25,714)		(10,995)		—		(1,970)		(38,679)
Balance as of March 31, 2022	$	13,734	$	2,628	$	3,028	$	486	$	19,876

The total reserves described above are summarized as components of the Company’s consolidated balance sheets as follows (in thousands):

	March 31,
	2022		2021
Reduction of accounts receivable, net	$	486	$	79
Component of accrued expenses and other current liabilities	19,390		1,315
Total revenue-related reserves	$	19,876	$	1,394